342 related articles for article (PubMed ID: 29077521)
41. The role of upper airway pathology as a co-morbidity in severe asthma.
Licari A; Brambilla I; De Filippo M; Poddighe D; Castagnoli R; Marseglia GL
Expert Rev Respir Med; 2017 Nov; 11(11):855-865. PubMed ID: 28918658
[TBL] [Abstract][Full Text] [Related]
42. Airway epithelial-targeted nanoparticles for asthma therapy.
Kan S; Hariyadi DM; Grainge C; Knight DA; Bartlett NW; Liang M
Am J Physiol Lung Cell Mol Physiol; 2020 Mar; 318(3):L500-L509. PubMed ID: 31913649
[TBL] [Abstract][Full Text] [Related]
43. Asthma phenotypes in children and stratified pharmacological treatment regimens.
Iordanidou M; Loukides S; Paraskakis E
Expert Rev Clin Pharmacol; 2017 Mar; 10(3):293-303. PubMed ID: 27936975
[TBL] [Abstract][Full Text] [Related]
44. Effect of diosmetin on airway remodeling in a murine model of chronic asthma.
Ge A; Liu Y; Zeng X; Kong H; Ma Y; Zhang J; Bai F; Huang M
Acta Biochim Biophys Sin (Shanghai); 2015 Aug; 47(8):604-11. PubMed ID: 26033789
[TBL] [Abstract][Full Text] [Related]
45. Effect of montelukast on markers of airway remodeling in children with asthma.
Tenero L; Piazza M; Sandri M; Azzali A; Chinellato I; Peroni D; Boner A; Piacentini G
Allergy Asthma Proc; 2016 Sep; 37(5):77-83. PubMed ID: 27657514
[TBL] [Abstract][Full Text] [Related]
46. Pharmacotherapy for the treatment of asthma: current treatment options and future directions.
Choby GW; Lee S
Int Forum Allergy Rhinol; 2015 Sep; 5 Suppl 1():S35-40. PubMed ID: 26335835
[TBL] [Abstract][Full Text] [Related]
47. Biologic and New Therapies in Asthma.
Tabatabaian F; Ledford DK; Casale TB
Immunol Allergy Clin North Am; 2017 May; 37(2):329-343. PubMed ID: 28366480
[TBL] [Abstract][Full Text] [Related]
48. Caffeic acid phenethyl ester alleviates asthma by regulating the airway microenvironment via the ROS-responsive MAPK/Akt pathway.
Ma Y; Zhang JX; Liu YN; Ge A; Gu H; Zha WJ; Zeng XN; Huang M
Free Radic Biol Med; 2016 Dec; 101():163-175. PubMed ID: 27746262
[TBL] [Abstract][Full Text] [Related]
49. Asthma Phenotypes and Endotypes: Implications for Personalised Therapy.
Dean K; Niven R
BioDrugs; 2017 Oct; 31(5):393-408. PubMed ID: 28879503
[TBL] [Abstract][Full Text] [Related]
50. Redefining approaches to asthma: developing targeted biologic therapies.
Arron JR; Scheerens H; Matthews JG
Adv Pharmacol; 2013; 66():1-49. PubMed ID: 23433454
[TBL] [Abstract][Full Text] [Related]
51. Anti-IL-4/-13 based therapy in asthma.
Walsh GM
Expert Opin Emerg Drugs; 2015 Sep; 20(3):349-52. PubMed ID: 26021492
[TBL] [Abstract][Full Text] [Related]
52. Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease.
Kuruvilla ME; Lee FE; Lee GB
Clin Rev Allergy Immunol; 2019 Apr; 56(2):219-233. PubMed ID: 30206782
[TBL] [Abstract][Full Text] [Related]
53. Pharmacotherapy of asthma: regular treatment or on demand?
Montuschi P; Pagliari G; Fuso L
Ther Adv Respir Dis; 2009 Aug; 3(4):175-91. PubMed ID: 19671618
[TBL] [Abstract][Full Text] [Related]
54. Lebrikizumab for the treatment of asthma.
Antoniu SA
Expert Opin Investig Drugs; 2016 Oct; 25(10):1239-49. PubMed ID: 27554950
[TBL] [Abstract][Full Text] [Related]
55. New perspectives in pharmacological treatment of mild persistent asthma.
Montuschi P; Barnes PJ
Drug Discov Today; 2011 Dec; 16(23-24):1084-91. PubMed ID: 21930234
[TBL] [Abstract][Full Text] [Related]
56. Severe asthma phenotypes and endotypes.
Agache I
Semin Immunol; 2019 Dec; 46():101301. PubMed ID: 31466925
[TBL] [Abstract][Full Text] [Related]
57. Ovalbumin-induced allergic inflammation lead to structural alterations in mouse model and protective effects of intranasal curcumin: A comparative study.
Subhashini ; Chauhan PS; Singh R
Allergol Immunopathol (Madr); 2016; 44(3):246-56. PubMed ID: 27046748
[TBL] [Abstract][Full Text] [Related]
58. Non-anticoagulant derivatives of heparin for the management of asthma: distant dream or close reality?
Shastri MD; Peterson GM; Stewart N; Sohal SS; Patel RP
Expert Opin Investig Drugs; 2014 Mar; 23(3):357-73. PubMed ID: 24387080
[TBL] [Abstract][Full Text] [Related]
59. The discovery and development of omalizumab for the treatment of asthma.
Licari A; Marseglia G; Castagnoli R; Marseglia A; Ciprandi G
Expert Opin Drug Discov; 2015; 10(9):1033-42. PubMed ID: 25979110
[TBL] [Abstract][Full Text] [Related]
60. Investigational approaches for unmet need in severe asthma.
Watchorn D; Menzies-Gow A
Expert Rev Respir Med; 2022 Jun; 16(6):661-678. PubMed ID: 35786146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
